Wells Fargo Sees 112% Upside in Design Therapeutics Ahead of 2027 Friedreich Ataxia Data

Analysts see GeneTAC protein gains translating into functional benefit in Friedreich ataxia. Cash of $207.4 million is guided to fund plans into 2029.